377 related articles for article (PubMed ID: 10619215)
21. [Clinically relevant drug interactions with new generation antidepressants and antipsychotics].
Eckert A
Ther Umsch; 2009 Jun; 66(6):485-92. PubMed ID: 19496045
[TBL] [Abstract][Full Text] [Related]
22. Predictors of drug response in depression.
Joyce PR; Paykel ES
Arch Gen Psychiatry; 1989 Jan; 46(1):89-99. PubMed ID: 2562916
[TBL] [Abstract][Full Text] [Related]
23. Treatment response in melancholia.
Brown WA
Acta Psychiatr Scand Suppl; 2007; (433):125-9. PubMed ID: 17280578
[TBL] [Abstract][Full Text] [Related]
24. Tricyclic nonresponders: phenomenology and treatment.
Roose SP; Glassman AH; Walsh BT; Woodring S
Am J Psychiatry; 1986 Mar; 143(3):345-8. PubMed ID: 3953869
[TBL] [Abstract][Full Text] [Related]
25. [Pharmacological treatment of depression].
Castro P; Wilmotte J
Rev Med Brux; 1994; 15(5):306-10. PubMed ID: 7984847
[TBL] [Abstract][Full Text] [Related]
26. A differential response to nortriptyline and fluoxetine in melancholic depression: the importance of age and gender.
Joyce PR; Mulder RT; Luty SE; McKenzie JM; Rae AM
Acta Psychiatr Scand; 2003 Jul; 108(1):20-3. PubMed ID: 12807373
[TBL] [Abstract][Full Text] [Related]
27. Antidepressants in the treatment of migraine headache.
Punay NC; Couch JR
Curr Pain Headache Rep; 2003 Feb; 7(1):51-4. PubMed ID: 12525271
[TBL] [Abstract][Full Text] [Related]
28. Melancholia with onset during treatment with SSRIs.
Swartz CM; Guadagno G
Ann Clin Psychiatry; 1998 Dec; 10(4):177-9. PubMed ID: 9988059
[TBL] [Abstract][Full Text] [Related]
29. Differential response patterns to MAO inhibitors and tricyclics.
Nies A
J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):70-7. PubMed ID: 6376487
[TBL] [Abstract][Full Text] [Related]
30. Antidepressant usage in schizophrenia.
Plasky P
Schizophr Bull; 1991; 17(4):649-57. PubMed ID: 1687176
[TBL] [Abstract][Full Text] [Related]
31. An analysis of the diffusion of new antidepressants: variety, quality, and marketing efforts.
Berndt ER; Bhattacharjya A; Mishol DN; Arcelus A; Lasky T
J Ment Health Policy Econ; 2002 Mar; 5(1):3-19. PubMed ID: 12529566
[TBL] [Abstract][Full Text] [Related]
32. Reversible monoamine oxidase-A inhibitors in resistant major depression.
Nolen WA; Hoencamp E; Bouvy PF; Haffmans PM
Clin Neuropharmacol; 1993; 16 Suppl 2():S69-76. PubMed ID: 8313400
[TBL] [Abstract][Full Text] [Related]
33. Expanding psychopharmacologic treatment options for the depressed medical patient.
Stoudemire A
Psychosomatics; 1995; 36(2):S19-26. PubMed ID: 7724709
[TBL] [Abstract][Full Text] [Related]
34. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
35. The superiority of antidepressant medication to cognitive behavior therapy in melancholic depressed patients: a 12-week single-blind randomized study.
Parker G; Blanch B; Paterson A; Hadzi-Pavlovic D; Sheppard E; Manicavasagar V; Synnott H; Graham RK; Friend P; Gilfillan D; Perich T
Acta Psychiatr Scand; 2013 Oct; 128(4):271-81. PubMed ID: 23240706
[TBL] [Abstract][Full Text] [Related]
36. New developments in the treatment of depression.
Montgomery SA
J Clin Psychiatry; 1999; 60 Suppl 14():10-5; discussion 31-5. PubMed ID: 10408420
[TBL] [Abstract][Full Text] [Related]
37. Circulating cytotoxic T cells and natural killer cells as potential predictors for antidepressant response in melancholic depression. Restoration of T regulatory cell populations after antidepressant therapy.
Grosse L; Carvalho LA; Birkenhager TK; Hoogendijk WJ; Kushner SA; Drexhage HA; Bergink V
Psychopharmacology (Berl); 2016 May; 233(9):1679-88. PubMed ID: 25953327
[TBL] [Abstract][Full Text] [Related]
38. Weight gain and antidepressants.
Fava M
J Clin Psychiatry; 2000; 61 Suppl 11():37-41. PubMed ID: 10926053
[TBL] [Abstract][Full Text] [Related]
39. The efficacy, safety and tolerability of antidepressants in late life depression: a meta-analysis.
Mittmann N; Herrmann N; Einarson TR; Busto UE; Lanctôt KL; Liu BA; Shulman KI; Silver IL; Narango CA; Shear NH
J Affect Disord; 1997 Dec; 46(3):191-217. PubMed ID: 9547117
[TBL] [Abstract][Full Text] [Related]
40. Treatment resistant depression in an Australian context. II: Outcome of a series of patients.
Wilhelm K; Mitchell P; Sengoz A; Hickie I; Brodaty H; Boyce P
Aust N Z J Psychiatry; 1994 Mar; 28(1):23-33. PubMed ID: 7915107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
